Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Appendicitis01:19

Appendicitis

Appendicitis is an acute inflammatory condition of the vermiform appendix, most commonly caused by obstruction of its lumen. The appendix is a narrow, blind-ended pouch that extends from the cecum, making it particularly prone to obstruction. Causes include fecaliths, lymphoid hyperplasia (often after viral infections), parasites, tumors, or foreign bodies. This obstruction initiates a cascade of pathological changes.Luminal Obstruction and Early InflammationAfter obstruction, normal mucosal...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Reasoning in machine vision by learning fast and slow thinking.

Nature communications·2026
Same author

Warm-started reinforcement learning for iterative 3D/2D liver registration.

International journal of computer assisted radiology and surgery·2026
Same author

Real Time Evaluation of Whole Organ Perfusion by Magnetic Resonance Imaging in Ex Vivo Machine-Perfused Liver.

NMR in biomedicine·2026
Same author

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses.

Hepatology (Baltimore, Md.)·2026
Same author

Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Nature reviews. Gastroenterology & hepatology·2025
Same author

Anticoagulation Practice and Risk of Portal Vein Thrombosis Following Pancreaticoduodenectomy or Total Pancreatectomy with Venous Resection: An International Multicentre Cohort Study.

Annals of surgery·2025
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Jul 5, 2026

The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

コランジオカルシノーマ (Cholangiocarcinoma) とは

Shahid A Khan1, Howard C Thomas, Brian R Davidson

  • 1Liver Unit, Division of Medicine, St Mary's Hospital Campus, Faculty of Medicine, Imperial College London, London, UK. shahid.khan@imperial.ac.uk

Lancet (London, England)
|October 11, 2005
PubMed
まとめ
この要約は機械生成です。

胆管がんであるコレランジオカルシノマは,ますます遅れて診断され,結果が悪くなっています. 手術による切除が唯一の治療法である一方で,肝臓移植と緩和性胆道排水は,進行した症例の選択肢です.

さらに関連する動画

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor
06:39

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor

Published on: May 23, 2025

関連する実験動画

Last Updated: Jul 5, 2026

The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor
06:39

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor

Published on: May 23, 2025

科学分野:

  • ヘパト・ビリヤル医学は,肝臓・胆管医学である.
  • 外科腫瘍学外科腫瘍学
  • 胃腸内科 胃腸内科

背景:

  • コランジオカルシノーマ (胆管がん) は,発症が遅い,診断が難しい,死亡率が高い重度の悪性腫瘍です.
  • 肝臓内コレランジオカルシノーマの発生率は,おそらく遺伝的および環境的要因のために,世界的に増加しています.
  • 現在の診断ツールには,MRI,CT,内視超音波,PETが含まれており,特定の患者の貴重な情報を提供しています.

研究 の 目的:

  • コランジオカルシノーマの現在の理解と管理を要約します.
  • 肝臓内胆管がんの診断方法と治療戦略を強調する.
  • 切除できない胆道がんの緩和ケアオプションについて議論する.

主な方法:

  • コランジオカルシノマの診断と治療に関する既存の文献のレビュー.
  • 診断目的のイメージング技術 (MRI,CT,EUS,PET) の分析
  • 外科的切除,肝移植,化学療法,放射線療法,および緩和的な介入の評価.

主要な成果:

  • 外科的切除は治療の唯一の選択肢であり,テクニックと患者の選択によって決定される.
  • ネオアジュバント化学放射線療法による肝臓移植は,選択された患者の長期的な生存に希望を示しています.
  • 化学療法と放射線治療は,手術不能の腫瘍ではほとんど効果がありません;胆道排水は緩和の鍵です.

結論:

  • コランジオカルシノマの管理には,治癒と緩和戦略のバランスをとる学際的なアプローチが必要です.
  • 早期診断と患者の選択は,胆管がんの治療結果を改善するために重要である.
  • フォトダイナミックセラピーなどの新しい緩和療法が,進行した症例の生活の質を向上させる可能性があります.